𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coxsackie B virus infections in new zealand patients with cardiac and non-cardiac diseases

✍ Scribed by Robert C. H. Lau


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
349 KB
Volume
11
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


From 1979 to 1981, a total of 910 cardiac patients and 776 noncardiac patients were studied and compared for evidence of coxsackie B virus infections. Of 78 cardiac patients with coxsackie B infection, 30 had pleurodynia, 18 myocarditis, and 20 pericarditis. The age-adjusted rates of infection per 100 cases of defined category were 7.2, 13.3, and 7.0, respectively. Of 69 noncardiac patients with coxsackie B infection, 27 presented with pyrexia of unknown origin, 14 with upper respiratory tract infection, and 9 with meningitis. The age-adjusted rates of infection per 100 population were 10.6, 11.0, and 8.4, respectively. The sex-specific, age-adjusted rates for both cardiac and noncardiac patients were generally higher in male than female. For cardiac patients, the highest percentage with coxsackie B virus infection occurred in the 20-39-year age group, while in the noncardiac group, it was the 0-19-year age group. Coxsackie B2 and B4 were the two most prevalent serotypes found in both cardiac and noncardiac patients. Coxsackie B infections occurred mainly during summer and autumn. The level of coxsackie B immunity in 1,020 normal persons aged 1-60 years and from all 18 health districts of New Zealand was studied. The geometric mean titre of antibody from these normal persons was highest for serotypes B2 and B4. The least prevalent type antibody was B6 where 970(95.1%) of normal persons tested had no antibody to this serotype. The percentage of normal persons with antibody-type present were 30.4, 63.4, 54.1, 71.3, and 51.8 for B1-5, respectively.


πŸ“œ SIMILAR VOLUMES


Morbidity and mortality from chronic hep
✍ Dr. Anna S. F. Lok; Ching-Lung Lai; Hau-Tim Chung; Johnson Y. N. Lau; Elsie K. Y πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 508 KB

Three-hundred forty-one HBsAg-positive family members of 152 patients with chronic hepatitis B virus infection (47 asymptomatic carriers, 59 with chronic hepatitis, 17 with cirrhosis and 29 with hepatocellular carcinoma) were prospectively studied to determine the morbidity and mortality from chroni

Chronic liver disease and cirrhosis amon
✍ Ana Mota; Jorge Areias; Margarida Fonseca Cardoso πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract The prevalence of infection with hepatitis B virus in Portugal is around 1% of the population; 20–30% of those infected typically develop cirrhosis. The study focuses on the epidemiological profile of patients with hepatitis B infection and liver damage, in particular, cirrhosis. Of the

Mutations within enhancer II and BCP reg
✍ Didik Setyo Heriyanto; Yoshihiko Yano; Takako Utsumi; Nungki Anggorowati; Hanggo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 1 views

## Abstract Studies on the characteristics of mutations within the hepatitis B virus (HBV) genome, their roles in the pathogenesis of advanced liver diseases, and the involvement of host properties of HBV‐infected individuals have not been conducted in subgenotype B3‐infected populations. For addre

IL28B alleles associated with poor hepat
✍ Pierre-Yves Bochud; StΓ©phanie Bibert; ZoltΓ‘n Kutalik; Etienne Patin; Julien Guer πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 375 KB πŸ‘ 2 views

Poynard owns stock in Biopredictive. He also consults for and is on the speakers' bureau of Merck. Dr. Pol consults for, advises, and is on the speakers' bureau of Boehringer Ingleheim, Abbott, and GlaxoSmithKline. He consults for, advises, is on the speakers' bureau of, and received grants from Roc